Literature DB >> 1381540

Interferon-inducible gene expression in chimpanzee liver infected with hepatitis C virus.

T Kato1, M Esumi, S Yamashita, K Abe, T Shikata.   

Abstract

The molecular host response to hepatitis C virus (HCV) infection was examined by isolation of HCV-induced genes from a cDNA library constructed from chimpanzee liver during the acute phase of hepatitis C. Two cDNA clones, 130-7 and 130-51, were obtained by differential hybridization with cDNA probes prepared from poly(A)+ RNAs of infected and uninfected livers. Northern blot analysis revealed that the 130-7 and 130-51 cDNAs were expressed as 1.5- and 1.0-kb products, respectively, in chimpanzee liver and that their induction rates of the two were 20 and 4, respectively. Nucleotide sequence analyses of these cDNA inserts showed that the sequence of cDNA 130-7 was that of a class I major histocompatibility antigen and that the sequence of cDNA 130-51 was 98% homologous with a human interferon-inducible mRNA. These results suggest that HCV infection may actively induce interferon, which in turn induces the expressions of these interferon-inducible genes. Furthermore, the high expression of HLA class I antigen in the acute phase of hepatitis C suggests that liver cell injury in HCV infection may be mediated by cytotoxic T cells that recognize viral antigen in association with HLA class I antigen.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1381540     DOI: 10.1016/0042-6822(92)90925-f

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  10 in total

Review 1.  Insights into antiviral innate immunity revealed by studying hepatitis C virus.

Authors:  Stacy M Horner
Journal:  Cytokine       Date:  2015-03-25       Impact factor: 3.861

2.  Detection of abundantly transcribed genes and gene translocation in human immunodeficiency virus-associated non-Hodgkin's lymphoma.

Authors:  V Tarantul; A Nikolaev; H Hannig; B Kalmyrzaev; I Muchoyan; V Maximov; V Nenasheva; V Dubovaya; G Hunsmann; W Bodemer
Journal:  Neoplasia       Date:  2001 Mar-Apr       Impact factor: 5.715

3.  Expression of interferon-alpha receptor mRNA in the liver in chronic liver diseases associated with hepatitis C virus: relation to effectiveness of interferon therapy.

Authors:  R Fukuda; N Ishimura; S Ishihara; A Tokuda; S Satoh; S Sakai; S Akagi; M Watanabe; S Fukumoto
Journal:  J Gastroenterol       Date:  1996-12       Impact factor: 7.527

4.  Comparative features of hepatitis C virus infection in humans and chimpanzees.

Authors:  C M Walker
Journal:  Springer Semin Immunopathol       Date:  1997

5.  Characterisation of a novel minisatellite that provides multiple splice donor sites in an interferon-induced transcript.

Authors:  M G Turri; K A Cuin; A C Porter
Journal:  Nucleic Acids Res       Date:  1995-06-11       Impact factor: 16.971

6.  Hepatitis C virus (HCV) genotype, tissue HCV antigens, hepatocellular expression of HLA-A,B,C, and intercellular adhesion-1 molecules. Clues to pathogenesis of hepatocellular damage and response to interferon treatment in patients with chronic hepatitis C.

Authors:  G Ballardini; P Groff; P Pontisso; F Giostra; R Francesconi; M Lenzi; D Zauli; A Alberti; F B Bianchi
Journal:  J Clin Invest       Date:  1995-05       Impact factor: 14.808

Review 7.  Immunopathogenesis of Hepatitis C Virus Infection.

Authors:  David E Kaplan
Journal:  Gastroenterol Clin North Am       Date:  2015-08-13       Impact factor: 3.806

8.  Focal distribution of hepatitis C virus RNA in infected livers.

Authors:  J David Stiffler; Minhhuyen Nguyen; Ji A Sohn; Chen Liu; David Kaplan; Christoph Seeger
Journal:  PLoS One       Date:  2009-08-18       Impact factor: 3.240

9.  Identification of a novel gene family that includes the interferon-inducible human genes 6-16 and ISG12.

Authors:  Nadeene Parker; Andrew C G Porter
Journal:  BMC Genomics       Date:  2004-01-19       Impact factor: 3.969

10.  Transmembrane serine protease TMPRSS2 activates hepatitis C virus infection.

Authors:  Mariko Esumi; Mariko Ishibashi; Hiromi Yamaguchi; Satomi Nakajima; Yuhi Tai; Sachiko Kikuta; Masahiko Sugitani; Tadatoshi Takayama; Maino Tahara; Makoto Takeda; Takaji Wakita
Journal:  Hepatology       Date:  2015-02       Impact factor: 17.425

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.